Sinar Eka Selaras Tbk. vs Kalbe Farma Tbk — how do they compare? Sinar Eka Selaras Tbk. trades at Rp284 (market cap 1.47T, 501.8K 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 23.2× Sinar Eka Selaras Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 501.8K). Which is the better fit depends on your goals.
| ERAL | KLBF | |
|---|---|---|
Market Cap | 1.47T | 34.17T |
Volume | 501.8K | 156.61M |
Lot | 5.02K | 1.57M |
Turnover | 141.93M | 111.23B |
Average Price | 282.83 | 710.21 |
Value | 141.93M | 111.23B |
Indicative Equilibrium Price | 284 | 705 |
Indicative Equilibrium Volume | 10 | 56.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →